HomeTYRA • NASDAQ
add
Tyra Biosciences Inc
Previous close
$19.10
Day range
$18.15 - $19.48
Year range
$10.38 - $20.67
Market cap
959.09M USD
Avg Volume
125.26K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 22.32M | 55.73% |
Net income | -18.19M | -53.13% |
Net profit margin | — | — |
Earnings per share | -0.35 | -25.00% |
EBITDA | -22.20M | -55.78% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 382.46M | 58.24% |
Total assets | 404.74M | 58.69% |
Total liabilities | 14.86M | 137.22% |
Total equity | 389.88M | — |
Shares outstanding | 52.54M | — |
Price to book | 2.57 | — |
Return on assets | -17.70% | — |
Return on capital | -18.38% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -18.19M | -53.13% |
Cash from operations | -22.03M | -123.70% |
Cash from investing | 18.07M | 44,180.49% |
Cash from financing | 200.32M | 53,175.27% |
Net change in cash | 196.36M | 2,164.34% |
Free cash flow | -16.67M | -124.08% |
About
Founded
2018
Headquarters
Website
Employees
49